Myricetin increases hepatic peroxisome proliferator-activated receptor protein expression and decreases plasma lipids and adiposity in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Chang, Chia Ju ^a   Tzeng, Thing Fong ^b   Liou, Shorong Shii ^c   Chang, Yuan Shiun ^a   Liu, I Min ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Pao Chien Hospital   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; CHOLESTEROL; CYTOCHROME P450 4A1; FAT DROPLET; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYRICETIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MEGADOSE; FATTY ACID OXIDATION; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID DIET; LIPID STORAGE; LOW DRUG DOSE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WEIGHT GAIN;

EID: 84859760154     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/787152     Document Type: Article

References (32)

1. Travers M. E., McCarthy M. I., Type 2 diabetes and obesity: Genomics and the clinic Human Genetics 2011 130 1 41 58
2. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nature Reviews Immunology 2006 6 10 772 783 (Pubitemid 44453463)
3. Padwal R. S., Majumdar S. R., Drug treatments for obesity: orlistat, sibutramine, and rimonabant Lancet 2007 369 9555 71 77 (Pubitemid 46027230)
4. Ong K. C., Khoo H. E., Biological effects of myricetin General Pharmacology 1997 29 2 121 126 (Pubitemid 27312361)
5. Ko C. H., Shen S. C., Lee T. J. F., Chen Y. C., Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells Molecular Cancer Therapeutics 2005 4 2 281 290 (Pubitemid 40340207)
6. Liu I. M., Liou S. S., Lan T. W., Hsu F. L., Cheng J. T., Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats Planta Medica 2005 71 7 617 621
7. Liu I. M., Tzeng T. F., Liou S. S., Lan T. W., Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats Life Sciences 2007 81 21-22 1479 1488
8. Ong K. C., Khoo H. E., Effects of myricetin on glycemia and glycogen metabolism in diabetic rats Life Sciences 2000 67 14 1695 1705
9. Sclafani A., Springer D., Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes Physiology and Behavior 1976 17 3 461 471
10. Chantret I., Rodolosse A., Barbat A., Dussaulx E., Brot-Laroche E., Zweibaum A., Rousset M., Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation Journal of Cell Science 1994 107 1 213 225 (Pubitemid 24039048)
11. Van Heek M., Compton D. S., France C. F., Tedesco R. P., Fawzi A. B., Graziano M. P., Sybertz E. J., Strader C. D., Davis H. R., Diet-induced obese mice develop peripheral, but not central, resistance to leptin Journal of Clinical Investigation 1997 99 3 385 390 (Pubitemid 27414794)
12. Zhou J. Y., Zhou S. W., Zhang K. B., Tang J. L., Guang L. X., Ying Y., Xu Y., Zhang L., Li D. D., Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats Biological and Pharmaceutical Bulletin 2008 31 6 1169 1176 (Pubitemid 351871171)
13. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 1972 18 6 499 502
14. Shanmugasundaram K. R., Visvanathan A., Dhandapani K., Effect of high-fat diet on cholesterol distribution in plasma lipoproteins, cholesterol esterifying activity in leucocytes, and erythrocyte membrane components studied: importance of body weight American Journal of Clinical Nutrition 1986 44 6 805 815 (Pubitemid 17209001)
15. Abbott R. D., Wilson P. W. F., Kannel W. B., Castelli W. P., High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study Arteriosclerosis 1988 8 3 207 211
16. Folch J., Lees M., Sloane-Stanley G. H., A simple method for the isolation and purification of total lipides from animal tissues The Journal of Biological Chemistry 1957 226 1 497 509
17. Brunt E. M., Janney C. G., Di Bisceglie A. M., Neuschwander-Tetri B. A., Bacon B. R., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions American Journal of Gastroenterology 1999 94 9 2467 2474 (Pubitemid 29420675)
18. Park C. H., Yamabe N., Noh J. S., Kang K. S., Tanaka T., Yokozawa T., The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice Biological and Pharmaceutical Bulletin 2009 32 10 1734 1740
19. Varga T., Czimmerer Z., Nagy L., PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation Biochimica et Biophysica Acta 2011 1812 8 1007 1022
20. Kraja A. T., Province M. A., Straka R. J., Ordovas J. M., Borecki I. B., Arnett D. K., Fenofibrate and metabolic syndrome Endocrine, Metabolic and Immune DisordersDrug Targets 2010 10 2 138 148
21. Mancini F. P., Lanni A., Sabatino L., Moreno M., Giannino A., Contaldo F., Colantuoni V., Goglia F., Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats FEBS Letters 2001 491 1-2 154 158 (Pubitemid 32172021)
22. Bjrntorp P., Sjstrm L., Number and size of adipose tissue fat cells in relation to metabolism in human obesity Metabolism 1971 20 7 703 713
23. Paccaud F., Schlter-Fasmeyer V., Wietlisbach V., Bovet P., Dyslipidemia and abdominal obesityan assessment in three general populations Journal of Clinical Epidemiology 2000 53 4 393 400 (Pubitemid 30216478)
24. Malloy M. J., Kane J. P., A risk factor for atherosclerosis: triglyceride-rich lipoproteins Advances in Internal Medicine 2001 47 111 136 (Pubitemid 33791976)
25. Libby P., Current concepts of the pathogenesis of the acute coronary syndromes Circulation 2001 104 3 365 372 (Pubitemid 32666962)
26. Ansell B. J., Watson K. E., Fogelman A. M., Navab M., Fonarow G. C., High-density lipoprotein function: recent advances Journal of the American College of Cardiology 2005 46 10 1792 1798 (Pubitemid 41579798)
27. Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B., Kromhout D., Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study Lancet 1993 342 8878 1007 1011 (Pubitemid 23314801)
28. Mandard S., Mller M., Kersten S., Peroxisome proliferator-activated receptor target genes Cellular and Molecular Life Sciences 2004 61 4 393 416 (Pubitemid 38316578)
29. Ferré P., The biology of peroxisome proliferators-activated receptors: relationship with lipid metabolism and insulin sensitivity Diabetes 2004 53 1 S43 S50
30. Briggs M. R., Yokoyama C., Wang X., Brown M. S., Goldstein J. L., Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence Journal of Biological Chemistry 1993 268 19 14490 14496 (Pubitemid 23195580)
31. Ginsberg H. N., Review: efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia Journal of Clinical Endocrinology and Metabolism 2006 91 2 383 392 (Pubitemid 43236897)
32. Park C. H., Yamabe N., Noh J. S., Kang K. S., Tanaka T., Yokozawa T., The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice Biological and Pharmaceutical Bulletin 2009 32 10 1734 1740